Recursion Pharmaceuticals: -17.3%, fresh sell signal
Recursion Pharmaceuticals plunges 17.3% as a fresh Sell signal fires
Recursion Pharmaceuticals: -17.3%, fresh sell signal
Our view last week
Recursion Pharmaceuticals' fresh buy signal closes its first week down 6.3%: sellers are back in control of the volume and the weekly structure is flashing early fatigue signs, even with a double bottom in the 3.0 area and a 37% rebound still behind it. This week's technical analysis flags caution from the confirmation, in a Health Care sector still running strong — one to watch for swing trading setups.
This week's summary
Recursion Pharmaceuticals stock plunges 17.3% this week as a fresh Sell signal fires: the caution flagged last week has now played out, with sellers firmly back in control and only 16.7% of the day's volume coming from buyers. Price is back at the edge of the double bottom in the 2.9 area, on a highly volatile name. This week's technical analysis has signal strength at 98 out of 100: "downtrend making lower lows, pace holding". Trading not recommended.
IQS Phase
74
in tension
Signal Strength
98
downtrend making lower lows, pace holding
Sizing
STANDARD
Ranking
#20 / 140
New us stocks
Trade P&L %
+0.00%
from signal to today
restricted Platinum content